Pediatric Cardiology News

Around 4% of adolescents in the United States meet the AAP’s eligibility criteria for metabolic and bariatric surgery, according to findings published in Pediatrics.

Regeneron Pharmaceuticals announced the FDA extended its approval of alirocumab as an adjunct to diet and other LDL-lowering therapies to include patients aged 8 years and older with heterozygous familial hypercholesterolemia.

In a cohort of American Indian individuals, more than 70% of young adults and more than 50% of adolescents had dyslipidemia, and some had subclinical or clinical heart disease, according to new data from the Strong Heart Study.

Lantheus Holdings announced the FDA has approved the supplemental new drug application for its perflutren lipid microsphere injection to improve ultrasound imaging in pediatric patients with suboptimal echocardiograms.

A new report from the AAP urges that pediatricians emphasize high quality nutrition, physical activity and adequate sleep, among other factors, to combat obesity in their patients.

Atopic dermatitis in children may be associated with metabolic syndrome and nonalcoholic fatty liver disease, according to a study.

Motivational interviewing, a weight loss intervention recommended by the AAP, showed no benefit reducing childhood obesity during a recent study, according to research published in Pediatrics.

Data show about one in four children admitted with acute decompensated HF develops cardiogenic shock with 24 hours, with high risk for in-hospital mortality that increases with escalating cardiogenic shock stage.

When children aged 8 to 15 years were screened for risk for before participating in sports, the diagnostic yield for identifying those at risk was higher in those aged 12 years or older, researchers reported.

Artificial intelligence may have a role in the early detection of rheumatic heart disease using mitral regurgitation jet analysis, according to study findings published in the Journal of the American Heart Association.